Costly drugs to weigh on U.S. employers’ expenses in 2018: survey

(Reuters) – U.S. employers are bracing for higher health care expenses in 2018 as spending on new drugs to treat diseases such as cancer, multiple sclerosis and hepatitis C is expected to rise more than 7 percent, according to consultancy firm Mercer.  continue to full story

Sunday 25th February 2018